974
Participants
Start Date
April 24, 2020
Primary Completion Date
July 6, 2021
Study Completion Date
August 6, 2021
pathogen reduced SARS-CoV-2 convalescent plasma
Convalescent COVID-19 donor plasma is the liquid part of blood that is collected from patients who have recovered from COVID-19 infection. This plasma contains SARS-CoV-2 specific antibodies that may help fight the infection.
Placebo
Lactated Ringer's solution with multivitamins
University at Buffalo/Buffalo General Medical Center, Buffalo
Rochester General Hospital, Rochester
MedStar Health Research Institute/MedStar Washington Hospital Center, Washington D.C.
University of Maryland, Baltimore (University of Maryland Medical Center), Baltimore
Virginia Commonwealth University, Richmond
Sentara Norfolk General Hospital, Norfolk
Cleveland Clinic Florida, Weston
Vanderbilt University Medical Center, Nashville
Meharry Medical College, Nashville
University of Mississippi Medical Center, Jackson
The Ohio State University Wexner Medical Center and James Cancer Hospital, Columbus
Cleveland Clinic Ohio, Cleveland
University of Minnesota, Minneapolis
Loyola University Medical Center, Maywood
University of Chicago, Chicago
The University of Kansas Medical Center, Kansas City
Our Lady of the Lake Regional Medical Center, Baton Rouge
University of Arkansas for Medical Sciences, Little Rock
University of Colorado Denver, Aurora
University of Utah Health, Salt Lake City
Utah Valley Hospital, Provo
University of New Mexico Health Sciences Center, Albuquerque
Scripps Health, La Jolla
University of Washington, Seattle
Beth Israel Deaconess Medical Center, Boston
Newton-Wellelsey Hospital, Newton
Dolly Parton
UNKNOWN
National Center for Advancing Translational Sciences (NCATS)
NIH
Vanderbilt University Medical Center
OTHER